Research ArticleOriginal Article
Open Access

Neonatal short-term outcomes in infants with intrauterine growth restriction

Monica G. Hasmasanu, Sorana D. Bolboaca, Melinda I. Baizat, Tudor C. Drugan and Gabriela C. Zaharie
Saudi Medical Journal August 2015, 36 (8) 947-953; DOI: https://doi.org/10.15537/smj.2015.8.11533

References

  1. ↵
    1. Demicheva E,
    2. Crispi F
    (2014) Long-term follow-up of intrauterine growth restriction: cardiovascular disorders. Fetal Diagn Ther 36:143–153.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Lausman A,
    2. Kingdom J,
    3. Gagnon R,
    4. Basso M,
    5. Bos H,
    6. et al.,
    7. Maternal Fetal Medicine Committee
    (2013) Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can 35:741–757, English/French.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Rizzo G,
    2. Arduini D
    (2009) Intrauterine growth restriction: diagnosis and management. A review. Minerva Ginecol 61:411–420.
    OpenUrlPubMed
  4. ↵
    1. Mayer C,
    2. Joseph KS
    (2013) Fetal growth: a review of terms, concepts and issues relevant to obstetrics. Ultrasound Obstet Gynecol 41:136–145.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Sato Y,
    2. Benirschke K,
    3. Marutsuka K,
    4. Yano Y,
    5. Hatakeyama K,
    6. Iwakiri T,
    7. et al.
    (2013) Associations of intrauterine growth restriction with placental pathological factors, maternal factors and fetal factors;clinicopathological findings of 257 Japanese cases. Histol Histopathol 28:127–132.
    OpenUrlPubMed
  6. ↵
    1. Hovdenak N,
    2. Haram K
    (2012) Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 164:127–132.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Muhammad T,
    2. Khattak AA,
    3. Shafiq-ur-Rehman,
    4. Khan MA,
    5. Khan A,
    6. Khan MA
    (2010) Maternal factors associated with intrauterine growth restriction. J Ayub Med Coll Abbottabad 22:64–69.
    OpenUrlPubMed
  8. ↵
    1. Olusanya BO
    (2010) Intrauterine growth restriction in a low-income country: Risk factors, adverse perinatal outcomes and correlation with current WHO Multicenter Growth Reference. Early Hum Dev 86:439–444.
    OpenUrlPubMed
  9. ↵
    1. Aucott SW,
    2. Donohue PK,
    3. Northington FJ
    (2004) Increased morbidity in severe early intrauterine growth restriction. J Perinatol 24:435–440.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Sbârcea A,
    2. Râcă N
    (2012) Evaluation of Risk Factors Involved in Intrauterine Growth Restriction. Studia Universitatis “Vasile Goldiş”, Seria Ştiinţele Vieţi 22:225–233.
    OpenUrl
  11. ↵
    1. Taketomo CK,
    2. Hodding JH,
    3. Kraus DM
    , eds (2007) Pediatric Dosage Handbook (Lexi-Comp, Hudson (OH)), 14th ed.
  12. ↵
    1. MacDonald MG,
    2. Mullett MD,
    3. Seshia MMK
    1. Ogata ES
    (2005) in Avery’s Neonatology: Pathophysiology and Management of the Newborn, Carbohydrate homeostasis, eds MacDonald MG, Mullett MD, Seshia MMK (Lippincott Williams & Wilkins, Philadelphia (PA)), 6th ed, pp 876–891.
  13. ↵
    1. Ognean ML
    , ed (2010) Clinical guidelines in Neonatology. Guideline 14/Revision 0 [Internet], Diagnosis and treatment of hypoglycemia newborn. [Romanian; Accessed 2014 Dec 2], Available from:http://www.ms.ro/documente/14%20diagnosticul%20si%20tratamentul%20hipoglicemiei%20neonatale_9180_7493.pdf.
  14. ↵
    1. Gregory KE,
    2. Deforge CE,
    3. Natale KM,
    4. Phillips M,
    5. Van Marter LJ
    (2011) Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation. Adv Neonatal Care 11:155–164, quiz 165-166.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Wiedmeier SE,
    2. Henry E,
    3. Sola-Visner MC,
    4. Christensen RD
    (2009) Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol 29:130–136.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Ognean ML
    , ed (2010) Practical Guidelines for Neonatology. Guideline 13/Revision 1 [Internet], Follow the newborn at risk for neurological sequelae and development. [Romanian; Accessed 2014 Dec 2], Available from:http://www.ms.ro/documente/13%20urmarirea%20nou%20nascutului%20cu%20risc%20pentru%20sechele%20neurologice%20si%20de%20dezvoltare_9180_7492.pdf.
  17. ↵
    1. Volpe JJ
    1. Volpe JJ
    (2008) in Neurology of the Newborn, Intracranial Hemorrhage: Germinal Matrix-Intraventricular Hemorrhage in the Premature Infant, ed Volpe JJ (Saunders Elsevier, Philadelphia (PA)), 5th ed, pp 517–588.
  18. ↵
    1. Jäntschi L,
    2. Bolboacă SD
    (2010) Exact probabilities and confidence limits for binomial samples: applied to the difference between two proportions. ScientificWorldJournal 10:865–878.
    OpenUrl
  19. ↵
    1. Romo A,
    2. Carceller R,
    3. Tobajas J
    (2009) Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev 6(Suppl3):pS332–S336.
    OpenUrl
  20. ↵
    1. Motghare DD,
    2. Vaz FS,
    3. Pawaskar AM,
    4. Kulkarni MS
    (2014) Maternal determinants of intrauterine growth restriction in Goa, India: a case-control study. Global Journal of Medicine and Public Health 3:O8.
    OpenUrl
  21. ↵
    1. Hendrix N,
    2. Berghella V
    (2008) Non-placental causes of intrauterine growth restriction. Semin Perinatol 32:161–165.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Benavides-Serralde A,
    2. Hernández-Andrade E,
    3. Fernández-Delgado J,
    4. Plasencia W,
    5. Scheier M,
    6. Crispi F,
    7. et al.
    (2009) Three-dimensional sonographic calculation of the volume of intracranial structures in growth-restricted and appropriate-for-gestational age fetuses. Ultrasound Obstet Gynecol 33:530–537.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Sehested LT,
    2. Pedersen P
    (2014) Prognosis and risk factors for intrauterine growth retardation. Dan Med J 61:A4826.
    OpenUrl
  24. ↵
    1. Lees C,
    2. Marlow N,
    3. Arabin B,
    4. Bilardo CM,
    5. Brezinka C,
    6. Derks JB,
    7. et al.
    (2013) Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 42:400–408.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Bharti B,
    2. Bharti S
    (2005) A review of the Apgar score indicated that contextualization was required within the contemporary perinatal and neonatal care framework in different settings. J Clin Epidemiol 58:121–129.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Wilcox AJ
    (2001) On the importance--and the unimportance--of birthweight. Int J Epidemiol 30:1233–1241.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Salam RA,
    2. Das JK,
    3. Bhutta ZA
    (2014) Impact of intrauterine growth restriction on long-term health. Curr Opin Clin Nutr Metab Care 17:249–254.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Ortigosa Rocha C,
    2. Bittar RE,
    3. Zugaib M
    (2010) Neonatal outcomes of late-preterm birth associated or not with intrauterine growth restriction. Obstet Gynecol Int 2010:231842.
    OpenUrlPubMed
  29. ↵
    1. Chung KC,
    2. Swanson JA,
    3. Schmitz D,
    4. Sullivan D,
    5. Rohrich RJ
    (2009) Introducing evidence-based medicine to plastic and reconstructive surgery. Plast Reconstr Surg 123:1385–1389.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section